Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CCCC C4 Therapeutics, Inc.
$4.14 0.85% +0.04
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CCCC stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 504.4M
Enterprise value 295.3M
Trailing PE -3.2677165354331
Forward PE -4.010025
PEG Ratio 0.071120889300602
Enterprise to EBITDA -2.969
Enterprise to revenue 8.428
Price to book MRQ 1.9880714
Price to sales TTM 14.044366

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 35.0M
EBITDA -99448000
Diluted EPS TTM -0.91
Total Cash (MRQ) 253.7M
Current ratio (MRQ) 5.449
Operating Cash Flow (TTM) -84870000

CCCC trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CCCC News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.